Another Biotech Bites the Dust as Cambridge's Raze Shuts Down Post author:Sam Post published:December 13, 2017 Post category:BioPharma Reportedly, Raze Therapeutics, a biotech launched in 2014, has closed its doors. Source: BioSpace You Might Also Like Lilly's Cyramza Fails to Improve Overall Survival in Phase III Gastric Cancer Study December 10, 2017 Eli Lilly to Invest $72M in Indianapolis Diabetes Manufacturing October 22, 2017 3 Rock-Bottom Biotechs That Big Market Players are Betting On May 15, 2017
Lilly's Cyramza Fails to Improve Overall Survival in Phase III Gastric Cancer Study December 10, 2017
